Analyst consensus rating
Electra Therapeutics Analyst Rating: none
Direct answer
Electra Therapeutics's consensus rating is none.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $33.20.
Forecast evidence checked November 12, 2026.
Get free Electra Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $9.45
- Average price target
- $33.20
- High price target
- $36.00
- Low price target
- $30.00
- Low target gap
- +217.5%
- Target upside
- +251.3%
- High target gap
- +281%
- Target range width
- 63.5%
- Consensus rating
- none
- Analysts
- 5
- Evidence date
- November 12, 2026
- Valid through
- November 19, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Electra Therapeutics?
Electra Therapeutics has a verified none consensus. The same dataset has an average price target of $33.20.
How far are Electra Therapeutics's low and high targets from the recorded price?
The low target implies +217.5%, while the high target implies +281%.
How many analysts are included in Electra Therapeutics's consensus?
The verified consensus includes 5 analysts.
How is Electra Therapeutics's target upside or downside calculated?
The average target of $33.20 is divided by the recorded price of $9.45, then one is subtracted to produce +251.3%. This does not guarantee a future return.
When was Electra Therapeutics's analyst forecast verified?
The data was verified on 2026-11-12. The dataset is valid through 2026-11-19.